Evaluation of the Efficacy and Safety of NAFT-600 in Subjects With Tinea Pedis

NCT01290341 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

860

Enrollment

INDUSTRY

Sponsor class

Conditions

Tinea Pedis

Interventions

DRUG: NAFT-600 (naftin 2 % gel)
DRUG: Placebo

Sponsor

Merz North America, Inc.